HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Daniel O. Claassen, MD, MS

Director, Level 1 HDSA Center of Excellence, Vanderbilt University Medical Center


Daniel Claassen, MD, MS: Selective Knock-Downs in Huntington Disease

July 08, 2020

The associate professor of neurology at Vanderbilt University Medical Center spoke to the findings of a recent study in Huntington disease that assessed the feasibility of selectively knocking down mutant protein expression.